The Lausanne Integrative Metabolism and Nutrition Alliance (LIMNA) awards its first ever PhD prize to HaiPing Wang for her work on the support of CD36-mediated metabolic adaptation to regulatory T cell survival and function in tumors.
Haiping's thesis on "CD36-mediated metabolic adaptation supports regulatory T cell survival and function in tumors" was elaborated in the Ho Lab, part of the Ludwig Institute for Cancer Research Lausanne branch.
Before joining the Ho Lab, Haiping was a Master student at Seoul National University/Pharmacy college. "Since I started my PhD with a different background, I particularly enjoyed the learning-new-knowledge process and the communication with so many talented people from different scientific fields." notes Dr Wang as she looks to the future: "Thanks to all my supervisors´ support and encouragements, I would love to make a contribution to research on cancer and metabolic diseases in the academic area in the years ahead."
Haiping is currently pursuing her scientific career at the University of Geneva (Trajkovski Lab/Department of cell physiology and metabolism).